Ingredient news
Cohort Study Links Choline Source and Solubility to Dyslipidemia Patterns
By Nutranexa News |
A prospective cohort study in the American Journal of Clinical Nutrition found choline source and solubility were differentially associated with dyslipidemia risk, with gut microbiota as a key modifier.
Study Design
A prospective cohort study published in the American Journal of Clinical Nutrition examined how dietary choline from different food sources and solubility forms relates to dyslipidemia risk.
The analysis separated TMAO-associated and non-TMAO-associated patterns and tested whether gut microbiota composition modified the associations.
Main Findings
The authors found that dietary choline from distinct food sources and solubility forms was differentially associated with dyslipidemia risk.
For example, the adverse LDL-cholesterol association of egg-derived choline was observed only in individuals enriched in the Phascolarctobacterium genus, illustrating how gut microbiota can shape the relationship.
Buyer Takeaway
The findings reinforce that choline source and format, not just total intake, matter for how choline-based nutrition is positioned.
Ingredient buyers should keep source-specific and microbiome-aware evidence in mind when selecting between egg, lecithin-derived, and synthetic choline forms for food and supplement applications.